47% efficacy: Did Germany’s CureVac vaccine ultimately fail?

Germany’s Curevac was supposed to be a big player in COVID vaccinations. But now important tests have disappointed.

With an efficacy rate of just 47 percent, a much hyped vaccine is not useful. The EU had already ordered 400 million doses.